Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results among Patients with Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria

Minna Harmanen; Tuula Klaavuniemi; Marc Sorigue; Madiha Khan; Roosa Prusila; Esa Kari; Erika Alanne; Aino Rajamäki; Kaisa Sunela; Arja Jukkola; Esa Jantunen; Juan Manuel Sancho; Sanna Ketola; Hanne Kuitunen; Tuomas Selander; Aino Rönkä; Outi Kuittinen

doi:10.1097/HS9.0000000000000954

Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results among Patients with Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria

Minna Harmanen, Tuula Klaavuniemi, Marc Sorigue, Madiha Khan, Roosa Prusila, Esa Kari, Erika Alanne, Aino Rajamäki, Kaisa Sunela, Arja Jukkola, Esa Jantunen, Juan Manuel Sancho, Sanna Ketola, Hanne Kuitunen, Tuomas Selander, Aino Rönkä, Outi Kuittinen

Research output: Contribution to journal › Letter › Scientific

14 Downloads (Pure)

Original language	English
Article number	E954
Number of pages	4
Journal	HemaSphere
Volume	7
Issue number	10
DOIs	https://doi.org/10.1097/HS9.0000000000000954
Publication status	Published - 7 Oct 2023
Publication type	B1 Journal article

Funding

This work was funded by North Ostrobothnia Health Care District.

ASJC Scopus subject areas

Hematology

Access to Document

10.1097/HS9.0000000000000954Licence: CC BY-NC-ND

real_world_data__mcl2_protocol_demonstrates.1-2Final published version, 337 KBLicence: CC BY-NC-ND

https://urn.fi/URN:NBN:fi:tuni-202311099509Licence: CC BY-NC-ND

Cite this

Harmanen, M., Klaavuniemi, T., Sorigue, M., Khan, M., Prusila, R., Kari, E., Alanne, E., Rajamäki, A., Sunela, K., Jukkola, A., Jantunen, E., Sancho, J. M., Ketola, S., Kuitunen, H., Selander, T., Rönkä, A., & Kuittinen, O. (2023). Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results among Patients with Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria. HemaSphere, 7(10), Article E954. https://doi.org/10.1097/HS9.0000000000000954

@article{05c07b1eb2554cde8da81e798169f6a5,

title = "Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results among Patients with Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria",

author = "Minna Harmanen and Tuula Klaavuniemi and Marc Sorigue and Madiha Khan and Roosa Prusila and Esa Kari and Erika Alanne and Aino Rajam{\"a}ki and Kaisa Sunela and Arja Jukkola and Esa Jantunen and Sancho, {Juan Manuel} and Sanna Ketola and Hanne Kuitunen and Tuomas Selander and Aino R{\"o}nk{\"a} and Outi Kuittinen",

note = "Funding Information: This work was funded by North Ostrobothnia Health Care District.",

year = "2023",

month = oct,

day = "7",

doi = "10.1097/HS9.0000000000000954",

language = "English",

volume = "7",

number = "10",

}

Harmanen, M, Klaavuniemi, T, Sorigue, M, Khan, M, Prusila, R, Kari, E, Alanne, E, Rajamäki, A , Sunela, K , Jukkola, A, Jantunen, E, Sancho, JM, Ketola, S, Kuitunen, H, Selander, T, Rönkä, A & Kuittinen, O 2023, 'Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results among Patients with Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria', HemaSphere, vol. 7, no. 10, E954. https://doi.org/10.1097/HS9.0000000000000954

TY - JOUR

T1 - Real-world Data

T2 - MCL2 Protocol Demonstrates Excellent Treatment Results among Patients with Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria

AU - Harmanen, Minna

AU - Klaavuniemi, Tuula

AU - Sorigue, Marc

AU - Khan, Madiha

AU - Prusila, Roosa

AU - Kari, Esa

AU - Alanne, Erika

AU - Rajamäki, Aino

AU - Sunela, Kaisa

AU - Jukkola, Arja

AU - Jantunen, Esa

AU - Sancho, Juan Manuel

AU - Ketola, Sanna

AU - Kuitunen, Hanne

AU - Selander, Tuomas

AU - Rönkä, Aino

AU - Kuittinen, Outi

N1 - Funding Information: This work was funded by North Ostrobothnia Health Care District.

PY - 2023/10/7

Y1 - 2023/10/7

U2 - 10.1097/HS9.0000000000000954

DO - 10.1097/HS9.0000000000000954

M3 - Letter

AN - SCOPUS:85171793493

SN - 2572-9241

VL - 7

JO - HemaSphere

JF - HemaSphere

IS - 10

M1 - E954

ER -